None listed
Conditions
Interventions
Intervention1: Product 1- La! Tail
Product 2- Badam Tail Product 3- Shila X Tail Product 4- Mahanarayan Tail
Product 5- Maha Bhingraj Tail
Product 6- Rheumatil Gel
: Study will be conducted over a per
Sponsors
Dabur India Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1 Subjects in age group 18 -55 years 2 Healthy male and female subjects 3 Subjects with Fitzpatrick skin type III to V. 4 Subjects willing to give a written informed consent 5 Subjects willing to maintain the patch test in position for 24 hours 6 Subject having not participated in a similar investigation in the past two weeks 7 Subjects willing to come for regular follow up visits 8 Subjects ready to follow instructions during the study period 9 Subjects with sensitive skin type as per the score obtained on the skin type identification questionnaire in annexure-I and by dermatological evaluation for the confirmation of the same
Exclusion criteria
Exclusion criteria: •Infection, allergy on the tested area •Skin allergy antecedents or atopic subjects •Hyper sensitivity to any component of the tested products •Athletes and subjects with history of excessive sweating •Cutaneous disease which may influence the study result •Chronic illness which may influence the cutaneous state. •Subjects on oral corticosteroid •Subjects participating in any other cosmetic or therapeutic study. •Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects with sensitive skin typeTimepoint: Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects with sensitive skin type | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of dermatological safety of investigational products by 24hrs patch test under complete occlusion on healthy human subjects with sensitive skin typeTimepoint: 9 days | — |
Countries
India
Contacts
Public ContactDr Arun Gupta
MS Clinical Research Pvt. Ltd,
Outcome results
None listed